Search research articles
Contact Us
Filters
Showing results (141-150 of 151) with videos related to
Page
of 16
Sort By:
The Oncologist
|
January 18, 2019
Long-Term Safety Experience with Telotristat Ethyl Across Five Clinical Studies in Patients with Carcinoid Syndrome
Lowell B Anthony, Matthew H Kulke, Martyn E Caplin, et al.
Annals of Surgical Oncology
|
September 13, 2021
Management of Duodenal Neuroendocrine Tumors: Surgical versus Endoscopic Mucosal Resection
Catherine G Tran, Scott K Sherman, Mohammed O Suraju, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine
|
February 4, 2017
Localization of Unknown Primary Site with <sup>68</sup>Ga-DOTATOC PET/CT in Patients with Metastatic Neuroendocrine Tumor
Yusuf Menda, Thomas M O'Dorisio, James R Howe, et al.
Plos Biology
|
February 27, 2019
Time-dependent Pax3-mediated chromatin remodeling and cooperation with Six4 and Tead2 specify the skeletal myogenic lineage in developing mesoderm
Alessandro Magli, June Baik, Lauren J Mills, et al.
American Journal of Medical Genetics. Part A
|
March 2, 2021
Presacral neuroendocrine tumors associated with the Currarino syndrome
Aaron T Scott, Jonathon B Tessmann, Terry Braun, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine
|
October 7, 2018
Efficacy and Safety of High-Specific-Activity <sup>131</sup>I-MIBG Therapy in Patients with Advanced Pheochromocytoma or Paraganglioma
Daniel A Pryma, Bennett B Chin, Richard B Noto, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
January 16, 2020
Gene Expression Signatures Identify Novel Therapeutics for Metastatic Pancreatic Neuroendocrine Tumors
Aaron T Scott, Michelle Weitz, Patrick J Breheny, et al.
Pancreas
|
June 14, 2017
The North American Neuroendocrine Tumor Society Consensus Guidelines for Surveillance and Medical Management of Midgut Neuroendocrine Tumors
Jonathan R Strosberg, Thorvardur R Halfdanarson, Andrew M Bellizzi, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
March 9, 2021
High-Specific-Activity-<sup>131</sup>I-MIBG versus <sup>177</sup>Lu-DOTATATE Targeted Radionuclide Therapy for Metastatic Pheochromocytoma and Paraganglioma
Abhishek Jha, David Taïeb, Jorge A Carrasquillo, et al.
Journal of the National Cancer Institute
|
March 11, 2026
Quality of life and care experiences in a US multi-institutional neuroendocrine tumor cohort
Michael A O'Rorke, Tao Xu, Rhonda R Decook, et al.
Page
of 16
Search research articles
Search
Showing results (141-150 of 151) with videos related to
Sort By:
Page
of 16
The Oncologist
|
January 18, 2019
Long-Term Safety Experience with Telotristat Ethyl Across Five Clinical Studies in Patients with Carcinoid Syndrome
Lowell B Anthony, Matthew H Kulke, Martyn E Caplin, et al.
Annals of Surgical Oncology
|
September 13, 2021
Management of Duodenal Neuroendocrine Tumors: Surgical versus Endoscopic Mucosal Resection
Catherine G Tran, Scott K Sherman, Mohammed O Suraju, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine
|
February 4, 2017
Localization of Unknown Primary Site with <sup>68</sup>Ga-DOTATOC PET/CT in Patients with Metastatic Neuroendocrine Tumor
Yusuf Menda, Thomas M O'Dorisio, James R Howe, et al.
Plos Biology
|
February 27, 2019
Time-dependent Pax3-mediated chromatin remodeling and cooperation with Six4 and Tead2 specify the skeletal myogenic lineage in developing mesoderm
Alessandro Magli, June Baik, Lauren J Mills, et al.
American Journal of Medical Genetics. Part A
|
March 2, 2021
Presacral neuroendocrine tumors associated with the Currarino syndrome
Aaron T Scott, Jonathon B Tessmann, Terry Braun, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine
|
October 7, 2018
Efficacy and Safety of High-Specific-Activity <sup>131</sup>I-MIBG Therapy in Patients with Advanced Pheochromocytoma or Paraganglioma
Daniel A Pryma, Bennett B Chin, Richard B Noto, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
January 16, 2020
Gene Expression Signatures Identify Novel Therapeutics for Metastatic Pancreatic Neuroendocrine Tumors
Aaron T Scott, Michelle Weitz, Patrick J Breheny, et al.
Pancreas
|
June 14, 2017
The North American Neuroendocrine Tumor Society Consensus Guidelines for Surveillance and Medical Management of Midgut Neuroendocrine Tumors
Jonathan R Strosberg, Thorvardur R Halfdanarson, Andrew M Bellizzi, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
March 9, 2021
High-Specific-Activity-<sup>131</sup>I-MIBG versus <sup>177</sup>Lu-DOTATATE Targeted Radionuclide Therapy for Metastatic Pheochromocytoma and Paraganglioma
Abhishek Jha, David Taïeb, Jorge A Carrasquillo, et al.
Journal of the National Cancer Institute
|
March 11, 2026
Quality of life and care experiences in a US multi-institutional neuroendocrine tumor cohort
Michael A O'Rorke, Tao Xu, Rhonda R Decook, et al.
Page
of 16